The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655
Monnier, L., Lapinski, H., & Colette, C. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.881 · Cited by 1,461
Heerspink, H. J. L., Perkins, B. A., Fitchett, D. H., Husain, M., & Cherney, D. Z. I. (2016) · Circulation · doi:10.1161/circulationaha.116.021887 · Cited by 1,376
Self-citationCherney, D. Z. I., Perkins, B. A., Soleymanlou, N., Maione, M., Lai, V., Lee, A., Fagan, N. M., Woerle, H. J., Johansen, O. E., Broedl, U. C., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005081 · Cited by 1,329
Self-citationMetabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
Ferrannini, E., Muscelli, E., Frascerra, S., Baldi, S., Mari, A., Heise, T., Broedl, U. C., & Woerle, H.-J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72227 · Cited by 1,134
Bolinder, J., Ljunggren, Ö., Kullberg, J., Johansson, L., Wilding, J., Langkilde, A. M., Sugg, J., & Parikh, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2260 · Cited by 867
Blood Pressure Lowering in Type 2 Diabetes: A Systematic Review and Meta-analysis
Emdin, C. A., Rahimi, K., Neal, B., Callender, T., Perkovic, V., & Patel, A. (2015) · JAMA · doi:10.1001/jama.2014.18574 · Cited by 854
Diabetes and hypertension: a position statement by the American Diabetes Association
de Boer, I. H., Bangalore, S., Benetos, A., Davis, A. M., Michos, E. D., Muntner, P., Rossing, P., Zoungas, S., & Bakris, G. (2017) · Diabetes Care · doi:10.2337/dci17-0026 · Cited by 714
Ferrannini, E., Baldi, S., Frascerra, S., Astiarraga, B., Heise, T., Bizzotto, R., Mari, A., Pieber, T. R., & Muscelli, E. (2016) · Diabetes · doi:10.2337/db15-1356 · Cited by 712
Bonner, C., Kerr-Conte, J., Gmyr, V., Queniat, G., Moerman, E., Thévenet, J., Beaucamps, C., Delalleau, N., Popescu, I., Malaisse, W. J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3828 · Cited by 670
Vallon, V., & Thomson, S. C. (2017) · Diabetologia · doi:10.1007/s00125-016-4157-3 · Cited by 635
Zaccardi, F., Webb, D. R., Htike, Z. Z., Youssef, D., Khunti, K., & Davies, M. J. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12670 · Cited by 489
Roden, M., Weng, J., Eilbracht, J., Delafont, B., Kim, G., Woerle, H. J., & Broedl, U. C. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70084-6 · Cited by 450
Hawley, S. A., Ford, R. J., Smith, B. K., Gowans, G. J., Mancini, S. J., Pitt, R. D., Day, E. A., Salt, I. P., Steinberg, G. R., & Hardie, D. G. (2016) · Diabetes · doi:10.2337/db16-0058 · Cited by 391
Cherney, D. Z. I., Zinman, B., Inzucchi, S. E., Koitka-Weber, A., Mattheus, M., von Eynatten, M., & Wanner, C. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30182-1 · Cited by 383
Self-citationCanagliflozin slows progression of renal function decline independently of glycemic effects
Heerspink, H. J. L., Desai, M., Jardine, M., Balis, D., Meininger, G., & Perkovic, V. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016030278 · Cited by 361
Mazidi, M., Rezaie, P., Gao, H., & Kengne, A. P. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004007 · Cited by 347
Sodium-Glucose Co-transporters and Their Inhibition: Clinical Physiology
Ferrannini, E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.011 · Cited by 340
Cherney, D. Z. I., Cooper, M. E., Tikkanen, I., Pfarr, E., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Lund, S. S. (2018) · Kidney International · doi:10.1016/j.kint.2017.06.017 · Cited by 243
Self-citationDel Prato, S., Nauck, M., Durán‐Garcia, S., Maffei, L., Rohwedder, K., Theuerkauf, A., & Parikh, S. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12459 · Cited by 233
O'Neill, J., Fasching, A., Pihl, L., Patinha, D., Franzén, S., & Palm, F. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00689.2014 · Cited by 232
Devenny, J. J., Godonis, H. E., Harvey, S. J., Rooney, S., Cullen, M. J., & Pelleymounter, M. A. (2012) · Obesity · doi:10.1038/oby.2012.59 · Cited by 212
Acute kidney injury in patients on SGLT2 inhibitors: a propensity-matched analysis
Nadkarni, G. N., Ferrandino, R., Chang, A., Surapaneni, A., Chauhan, K., Poojary, P., Saha, A., Ferket, B., Grams, M. E., & Coca, S. G. (2017) · Diabetes Care · doi:10.2337/dc17-1011 · Cited by 188
SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial
Karg, M. V., Bosch, A., Kannenkeril, D., Striepe, K., Ott, C., Schneider, M. P., Boemke-Zelch, F., Linz, P., Nagel, A. M., Titze, J., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0654-z · Cited by 182
Cai, X., Yang, W., Gao, X., Chen, Y., Zhou, L., Zhang, S., Han, X., & Ji, L. (2018) · Obesity · doi:10.1002/oby.22066 · Cited by 181
Ferrannini, E., Baldi, S., Frascerra, S., Astiarraga, B., Barsotti, E., Clerico, A., & Muscelli, E. (2017) · Diabetes Care · doi:10.2337/dc16-2724 · Cited by 181
Pareek, M., Schauer, P. R., Kaplan, L. M., Leiter, L. A., Rubino, F., & Bhatt, D. L. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.014 · Cited by 177
Lytvyn, Y., Škrtić, M., Yang, G. K., Yip, P. M., Perkins, B. A., & Cherney, D. Z. I. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00555.2014 · Cited by 173
Self-citationGluconeogenesis and energy expenditure after a high-protein, carbohydrate-free diet
Veldhorst, M. A., Westerterp-Plantenga, M. S., & Westerterp, K. R. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27834 · Cited by 170
Škrtić, M., Yang, G. K., Perkins, B. A., Soleymanlou, N., Lytvyn, Y., von Eynatten, M., Woerle, H. J., Johansen, O. E., Broedl, U. C., Hach, T., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3396-4 · Cited by 159
Self-citationIntensive insulin therapy and weight gain in IDDM
Carlson, M. G., & Campbell, P. J. (1993) · Diabetes · doi:10.2337/diab.42.12.1700 · Cited by 155
Tanaka, H., Takano, K., Iijima, H., Kubo, H., Maruyama, N., Hashimoto, T., Arakawa, K., Togo, M., Inagaki, N., & Kaku, K. (2017) · Advances in Therapy · doi:10.1007/s12325-016-0457-8 · Cited by 140
Xu, L., & Ota, T. (2017) · Adipocyte · doi:10.1080/21623945.2017.1413516 · Cited by 134
Briand, F., Mayoux, E., Brousseau, E., Burr, N., Urbain, I., Costard, C., Mark, M., & Sulpice, T. (2016) · Diabetes · doi:10.2337/db16-0049 · Cited by 124
Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes
Cherney, D. Z. I., Perkins, B. A., Soleymanlou, N., Xiao, F., Zimpelmann, J., Woerle, H., Johansen, O. E., Broedl, U. C., von Eynatten, M., & Burns, K. D. (2014) · Kidney International · doi:10.1038/ki.2014.246 · Cited by 113
Self-citationESTERLINE, R. L., Vaag, A. A., Oscarsson, J., & Vora, J. P. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0832 · Cited by 106
Hallow, K. M., Gebremichael, Y., Helmlinger, G., & Vallon, V. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00497.2016 · Cited by 98
Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot study
Rajasekeran, H., Reich, H. N., Hladunewich, M., Cattran, D. C., Lovshin, J. A., Lytvyn, Y., Bjornstad, P., LAI, V. S., TSE, J. M., Cham, L., et al. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00445.2017 · Cited by 95
Self-citationOhgaki, R., Wei, L., Yamada, K., Hara, T., Kuriyama, C., Okuda, S., Ueta, K., Shiotani, M., Nagamori, S., & Kanai, Y. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232025 · Cited by 92
Bedtime Insulin/Daytime Glipizide: Effective Therapy for Sulfonylurea Failures in NIDDM
shank, M. L., Prato, S. D., & DeFronzo, R. A. (1995) · Diabetes · doi:10.2337/diab.44.2.165 · Cited by 91
Dual Regulation of Gluconeogenesis by Insulin and Glucose in the Proximal Tubules of the Kidney
Sasaki, M., Sasako, T., Kubota, N., Sakurai, Y., Takamoto, I., Kubota, T., Inagi, R., Seki, G., Goto, M., Ueki, K., et al. (2017) · Diabetes · doi:10.2337/db16-1602 · Cited by 79
Tang, H., Cui, W., Li, D., Wang, T., Zhang, J., Zhai, S., & Song, Y. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12785 · Cited by 77
Rajasekeran, H., Kim, S. J., Cardella, C. J., Schiff, J. R., Cattral, M. S., Cherney, D. Z. I., & Singh, S. K. S. (2017) · Diabetes Care · doi:10.2337/dc17-0237 · Cited by 77
Self-citationSGLT2 inhibitors-induced electrolyte abnormalities: An analysis of the associated mechanisms
Filippatos, T. D., Tsimihodimos, V., Liamis, G. L., & Elisaf, M. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.08.003 · Cited by 70
Horie, I., Abiru, N., Hongo, R., Nakamura, T., Ito, A., Haraguchi, A., Natsuda, S., Sagara, I., Ando, T., & Kawakami, A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.11.016 · Cited by 66
Li, J., Gong, Y., Li, C., Lu, Y., Liu, Y., & Shao, Y. (2017) · Medicine · doi:10.1097/md.0000000000007201 · Cited by 65
Nishimura, R., Osonoi, T., Kanada, S., Jinnouchi, H., Sugio, K., Omiya, H., Ubukata, M., Sakai, S., & Samukawa, Y. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12481 · Cited by 49
Solute carrier family 2, member 9 and uric acid homeostasis
Cheeseman, C. I. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32832ee3de · Cited by 47
Matsumura, M., Nakatani, Y., Tanka, S., Aoki, C., Sagara, M., Yanagi, K., Suzuki, K., & Aso, Y. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0274-3 · Cited by 41
Dapagliflozin suppresses glucagon signaling in rodent models of diabetes
Wang, M.-Y., Yu, X., Lee, Y., McCorkle, S. K., Chen, S., Li, J., Wang, Z. V., Davidson, J. A., Scherer, P. E., Holland, W. L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705845114 · Cited by 35
Sawada, Y., Izumida, Y., Takeuchi, Y., Aita, Y., Wada, N., Li, E., Murayama, Y., Piao, X., Shikama, A., Masuda, Y., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.081 · Cited by 31
Brady, J. A., & Hallow, K. M. (2017) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1030 · Cited by 30
Kurinami, N., Sugiyama, S., Nishimura, H., Morita, A., Yoshida, A., Hieshima, K., MIYAMOTO, F., Kajiwara, K., Jinnouchi, K., Jinnouchi, T., et al. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0580-6 · Cited by 29
Low-carbohydrate diet induces metabolic depression: a possible mechanism to conserve glycogen
Winwood-Smith, H. S., Franklin, C. E., & White, C. R. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00067.2017 · Cited by 20
Bujac, S. R., Parigi, A. D., Sugg, J. E., Grandy, S., Liptrot, T., Karpefors, M., Chamberlain, C., & Boothman, A.-M. (2014) · Diabetes Therapy · doi:10.1007/s13300-014-0090-y · Cited by 16
Predictors of the response of HbA1c and body weight after SGLT2 inhibition
Abe, T., Matsubayashi, Y., Yoshida, A., Suganami, H., Nojima, T., OSAWA, T., Ishizawa, M., Yamamoto, M., Fujihara, K., Tanaka, S., et al. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.10.003 · Cited by 12
SPAULDING, W. B., Spitzer, W. O., & Truscott, P. W. (1963) · PubMed · Cited by 2
Cited by
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.014 · Cited by 1,211
Basic Mechanisms of Diabetic Heart Disease
Ritchie, R. H., & Abel, E. D. (2020) · Circulation Research · doi:10.1161/circresaha.120.315913 · Cited by 708
Petrie, M. C., Verma, S., Docherty, K. F., Inzucchi, S. E., Anand, I., Belohlávek, J., Böhm, M., Chiang, C.-E., Chopra, V. K., de Boer, R. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.1906 · Cited by 531
McMurray, J. J. V., DeMets, D. L., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Bengtsson, O., Ponikowski, P., Sabatine, M. S., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1432 · Cited by 433
Molecular pathways that drive diabetic kidney disease
Mohandes, S., Doke, T., Hu, H., Mukhi, D., Dhillon, P., & Susztak, K. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165654 · Cited by 341
Metadata
- Authors
- Thomas, M. C., & Cherney, D. Z. I.
- Venue
- Diabetologia
- Published
- 2018-08-22
- Volume
- 61
- Issue
- 10
- Pages
- 2098-2107
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2883419804
- Cited by
- 348
- References
- 58
- FWCI
- 23.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.